1995
DOI: 10.1093/carcin/16.9.2167
|View full text |Cite
|
Sign up to set email alerts
|

Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes

Abstract: Recent studies indicate that cytochrome P450 (P450) 3A4 plays important roles in the activation of procarcinogens such as aflatoxin B1 and sterigmatocystin, as well as in the oxidation of a number of structurally diverse chemicals and endogenous compounds. Since P450 3A5 has been reported to be present at significant levels in liver microsomes in approximately 25% of human adults, we examined and compared the role of P450 3A4 and 3A5 in procarcinogen activation in humans. Immunoblot experiments with liver micr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
27
0
1

Year Published

1997
1997
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(28 citation statements)
references
References 0 publications
0
27
0
1
Order By: Relevance
“…CYP3A proteins have been assigned as the site of biotransformation of many drugs and procarcinogens [7,[38][39][40]. The high degree of similarity between the three major isoforms belonging to the CYP3A subfamily made any comparison of the substrate specificity of each isoform difficult.…”
Section: Discussionmentioning
confidence: 99%
“…CYP3A proteins have been assigned as the site of biotransformation of many drugs and procarcinogens [7,[38][39][40]. The high degree of similarity between the three major isoforms belonging to the CYP3A subfamily made any comparison of the substrate specificity of each isoform difficult.…”
Section: Discussionmentioning
confidence: 99%
“…Compared with CYP3A4, the CYP3A5 enzyme shows roughly the same substrate preference pattern but lower turnover rates (Aoyama et al, 1989;Wrighton et al, 1990;Yamazaki et al, 1995). However, CYP3A5 cannot metabolize some CYP3A4 substrates, such as erythromycin and quinidine (Wrighton et al, 1990).…”
Section: Discussionmentioning
confidence: 99%
“…Like AFB 1 , STC has been found to be metabolized by the cytochrome P4503A4 (Yamazaki et al, 1995) system to an active epoxide, which can then interact with nucleic acids to form a DNA-adduct at the N 7 -− guanyl position in the target cells (Essigmann et al, 1979(Essigmann et al, , 1980(Essigmann et al, , 1982Terao, 1983).…”
Section: -467mentioning
confidence: 99%